Holen Sie sich die Stockscreener-App
47.50
2.56%
-1.25
Handel nachbörslich:
47.00
-0.50
-1.05%
Schlusskurs vom Vortag:
$48.75
Offen:
$48.53
24-Stunden-Volumen:
2.11M
Relative Volume:
1.12
Marktkapitalisierung:
$8.88B
Einnahmen:
$29.52M
Nettoeinkommen (Verlust:
$-567.06M
KGV:
-12.98
EPS:
-3.66
Netto-Cashflow:
$-551.11M
1W Leistung:
+2.00%
1M Leistung:
+2.04%
6M Leistung:
+30.24%
1J Leistung:
-3.49%
1-Tages-Spanne:
$47.50
$48.77
1-Wochen-Bereich:
$46.16
$49.50
52-Wochen-Spanne:
$29.17
$62.40
Revolution Medicines Inc Stock (RVMD) Company Profile
Firmenname
Revolution Medicines Inc
Sektor
Branche
Telefon
415-766-3638
Adresse
700 SAGINAW DR, REDWOOD CITY, CA
Vergleichen Sie RVMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RVMD
Revolution Medicines Inc
|
47.50 | 9.11B | 29.52M | -567.06M | -551.11M | -3.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-12 | Fortgesetzt | Raymond James | Strong Buy |
| 2025-09-05 | Eingeleitet | Truist | Buy |
| 2025-08-19 | Eingeleitet | Piper Sandler | Overweight |
| 2025-08-15 | Eingeleitet | Wells Fargo | Overweight |
| 2025-07-15 | Eingeleitet | Goldman | Buy |
| 2024-07-16 | Bestätigt | Needham | Buy |
| 2024-07-12 | Eingeleitet | Barclays | Overweight |
| 2024-07-08 | Eingeleitet | Jefferies | Buy |
| 2024-04-12 | Bestätigt | Needham | Buy |
| 2024-04-10 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-03-11 | Eingeleitet | Piper Sandler | Overweight |
| 2024-01-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-01-04 | Eingeleitet | Wedbush | Outperform |
| 2023-11-16 | Eingeleitet | Raymond James | Outperform |
| 2023-02-28 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-12-14 | Eingeleitet | Needham | Buy |
| 2022-10-21 | Eingeleitet | Oppenheimer | Outperform |
| 2022-05-20 | Eingeleitet | BofA Securities | Neutral |
| 2022-03-01 | Hochstufung | Stifel | Hold → Buy |
| 2021-09-23 | Eingeleitet | Stifel | Hold |
| 2021-08-12 | Herabstufung | Goldman | Buy → Neutral |
| 2021-05-18 | Eingeleitet | Goldman | Buy |
| 2020-05-21 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-03-09 | Eingeleitet | Cowen | Outperform |
| 2020-03-09 | Eingeleitet | Guggenheim | Buy |
| 2020-03-09 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Revolution Medicines Inc Aktie (RVMD) Neueste Nachrichten
Is Revolution Medicines Inc. stock a bargain at current levelsTrend Reversal & Trade Opportunity Analysis - newser.com
Is Revolution Medicines Inc. Equity Warrant forming a reversal patternJuly 2025 WrapUp & Low Volatility Stock Suggestions - newser.com
Is a relief rally coming for Revolution Medicines Inc. holdersJuly 2025 Highlights & Weekly Breakout Opportunity Watchlist - newser.com
Full technical analysis of Revolution Medicines Inc. Equity Warrant stockWeekly Trade Summary & Growth-Oriented Investment Plans - newser.com
Using data filters to optimize entry into Revolution Medicines Inc. Equity WarrantJuly 2025 Update & Daily Chart Pattern Signals - newser.com
What earnings revisions data tells us about Revolution Medicines Inc.Market Risk Analysis & Long-Term Safe Investment Plans - newser.com
How analysts rate Revolution Medicines Inc. stock todayMarket Growth Review & Low Risk High Reward Ideas - newser.com
Will Revolution Medicines Inc. outperform the market2025 Technical Patterns & High Yield Stock Recommendations - newser.com
Measuring Revolution Medicines Inc. Equity Warrant’s beta against major indicesWeekly Investment Report & Weekly Stock Performance Updates - newser.com
How sentiment analysis helps forecast Revolution Medicines Inc. Equity Warrant2025 Sector Review & Fast Moving Stock Watchlists - newser.com
Revolution Medicines (RVMD) Stock Analysis: Unveiling a 56% Potential Upside Amidst Robust Buy Ratings - DirectorsTalk Interviews
Using data models to predict Revolution Medicines Inc. stock movementJuly 2025 Closing Moves & Stepwise Entry/Exit Trade Alerts - newser.com
How high can Revolution Medicines Inc. Equity Warrant stock goPortfolio Return Summary & High Conviction Investment Ideas - newser.com
What recovery options are there for Revolution Medicines Inc.2025 AllTime Highs & Detailed Earnings Play Alerts - newser.com
Can technical indicators confirm Revolution Medicines Inc.’s reversalTrade Exit Summary & AI Powered Buy/Sell Recommendations - newser.com
Why Revolution Medicines Inc. Equity Warrant stock appeals to dividend seekersOptions Play & Long-Term Capital Growth Ideas - newser.com
Should you wait for a breakout in Revolution Medicines Inc. Equity WarrantGap Up & Community Shared Stock Ideas - newser.com
How Revolution Medicines Inc. stock performs in interest rate cycles2025 Volume Leaders & Verified Momentum Stock Watchlist - newser.com
Revolution Medicines Inc. Equity Warrant stock volume spike explained2025 Volume Leaders & High Conviction Investment Ideas - newser.com
Revolution Medicines (NASDAQ:RVMD) Earns "Sell (D-)" Rating from Weiss Ratings - MarketBeat
How analysts revise price targets for Revolution Medicines Inc. (42Z) stockJuly 2025 Market Mood & Community Consensus Stock Picks - newser.com
What recovery options are there for Revolution Medicines Inc. Equity WarrantQuarterly Portfolio Summary & Low Volatility Stock Recommendations - newser.com
Revolution Medicines’ SWOT analysis: RAS inhibitor stock poised for growth amid fierce competition - Investing.com
Revolution Medicines’ SWOT analysis: RAS inhibitor stock poised for growth amid fierce competition By Investing.com - Investing.com South Africa
What analysts say about Revolution Medicines Inc stockTrendline Breakouts & Explosive Growth Opportunities - earlytimes.in
Did Leadership Moves Just Shift Revolution Medicines' (RVMD) Investment Narrative Ahead of Key Launches? - Yahoo Finance
Is now a turning point for Revolution Medicines Inc. Equity WarrantJuly 2025 Spike Watch & Low Volatility Stock Recommendations - newser.com
Assessing Revolution Medicines After Recent Cancer Breakthrough and 15% Monthly Rally - Yahoo Finance
Real time breakdown of Revolution Medicines Inc. stock performance2025 Technical Overview & Real-Time Stock Movement Alerts - newser.com
Revolution Medicines, Inc. (RVMD) Stock Analysis: Unveiling a 61.57% Upside Potential for Investors - DirectorsTalk Interviews
Using fundamentals and technicals on Revolution Medicines Inc. Equity WarrantTrade Signal Summary & Daily Profit Maximizing Tips - newser.com
How hedge fund analytics apply to Revolution Medicines Inc. stockQuarterly Earnings Report & Risk Managed Investment Entry Signals - newser.com
Short interest data insights for Revolution Medicines Inc.Weekly Investment Summary & High Accuracy Swing Trade Signals - newser.com
Evaluating Revolution Medicines Inc. with trendline analysisPortfolio Return Report & Stock Portfolio Risk Management - newser.com
Multi factor analysis applied to Revolution Medicines Inc. Equity WarrantTreasury Yields & Proven Capital Preservation Tips - newser.com
Will Revolution Medicines Inc. stock go up soon2025 Retail Activity & Weekly High Momentum Picks - newser.com
Will Revolution Medicines Inc. Equity Warrant stock benefit from upcoming earnings reportsBreakout Watch & Risk Controlled Stock Pick Alerts - newser.com
Advanced analytics toolkit walkthrough for Revolution Medicines Inc. Equity WarrantMarket Sentiment Review & Real-Time Stock Price Movement Reports - newser.com
Will Revolution Medicines Inc. Equity Warrant price bounce be sustainable2025 Top Gainers & Reliable Price Breakout Alerts - newser.com
Is Revolution Medicines Inc. stock vulnerable to regulatory risksSwing Trade & Reliable Volume Spike Trade Alerts - newser.com
Long term hold vs stop loss in Revolution Medicines Inc. Equity WarrantMarket Risk Analysis & Growth Oriented Trade Recommendations - newser.com
Published on: 2025-10-05 02:52:08 - newser.com
Finanzdaten der Revolution Medicines Inc-Aktie (RVMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):